Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-09-30

FDA Approved: DASATINIB — Supplemental Application (Dr.Reddys Laboratories Inc)

View source ↗

Summary

The FDA has approved a supplemental application for dasatinib from Dr. Reddy's Laboratories Inc, authorizing an update to the approval of the generic dasatinib …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DASATINIB (Dasatinib)

Snippet

SUPPL AP for DASATINIB (DASATINIB)